AI in Healthcare

The landscape of healthcare is undergoing a profound transformation, driven by the relentless pace of AI innovation. Today's insights from Zenovel's 'AI in Drug Discovery (2026)' report reveal that early adopters are experiencing 2-3x productivity gains, shrinking drug development timelines from years to just months. This isn't just about speed; it's about fundamentally rethinking how we approach R&D, from initial target identification to clinical application. With AI-discovered molecules now reaching advanced stages, the question is no longer if AI will change healthcare, but how deeply and how quickly it will integrate into every facet. What are the most significant ethical considerations we need to address as AI accelerates these critical processes? View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/linkedin/groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request. MIT, Google & IBM trained. Cross-Domain AI Expert. Quantum - AI Advocate. Democratized Blue Ocean Strategist & Operator. Real Estate Strategy & Intelligence Leader. View the full carousel: https://alex-companies.com/posts/healthcare-2026-07-17 George Arnold Alexander III Director, ALEX Companies Associate Broker, Alexander Tiffany Southwest, LLC +1 713.918.9951 · [email protected]